MARGARET MARY KREBS: Open Payments
NPI 1346085941 · BENSALEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,316 in 106 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $2,316
Food & beverage: $2,316
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $592 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $324 |
| Madrigal Pharmaceuticals | 6 | $271 |
| ABBVIE INC. | 11 | $199 |
| Lilly USA, LLC | 7 | $155 |
| Janssen Biotech, Inc. | 5 | $141 |
| Aimmune Therapeutics, Inc. | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Intercept Pharmaceuticals, Inc. | 3 | $76 |
| PFIZER INC. | 3 | $65 |
Products named: XIFAXAN, REZDIFFRA, ENTYVIO, OMVOH, TREMFYA, MAVYRET, ZENPEP, DUPIXENT.
Industry payments across PA — which companies pay providers there.
